[Form 4] KEWAUNEE SCIENTIFIC CORP /DE/ Insider Trading Activity

Rhea-AI Filing Summary

KEWAUNEE SCIENTIFIC CORP (/DE/, KEQU) reporting person Thomas David Hull III, who serves as President, CEO and a director, reported a sale of common stock on 09/29/2025. The Form 4 shows 1,854 shares were sold at a weighted average price of $43.42, with the trade price range disclosed as $43.00 to $43.85. After the sale, Hull beneficially owns 39,719 shares, held directly. The form was signed by an attorney-in-fact on 10/01/2025. The filing includes an undertaking to provide detailed per-price purchase information on request.

Insights

Financial Analyst

TL;DR: Insider sale of 1,854 shares at a weighted $43.42 reduced direct holdings to 39,719 shares; transaction appears routine.

The sale is modest in size relative to typical company-wide float for most issuers and does not, by itself, change control or signal a material shift in ownership. The filer is the company’s President and CEO, so monitoring insider activity over time is relevant, but this single transaction discloses only a routine disposition with a narrow price range ($43.00–$43.85). The Form 4 notes the weighted-average price and offers further breakdown on request, which supports transparency about execution prices.

Corporate Governance Expert

TL;DR: Director and executive disclosed a small, clearly documented sale; filing complies with Section 16 reporting requirements.

The Form 4 lists the reporting person’s roles and provides the required transaction details including date, amount sold, weighted-average price, and post-transaction beneficial ownership. The disclosure was executed by an attorney-in-fact and includes the explanatory remark about price range and availability of per-price details, which aligns with disclosure expectations. No additional governance issues are disclosed within this document.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

HULL THOMAS DAVID III

(Last) (First) (Middle)

2700 WEST FRONT STREET

(Street)

STATESVILLE NC 28677

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
KEWAUNEE SCIENTIFIC CORP /DE/ [ KEQU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, CEO

3. Date of Earliest Transaction (Month/Day/Year)
09/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/29/2025		S		1,854	D	$43.42(1)	39,719	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reflects the weighted average purchase price of the transactions reported. The price range of such transactions was $43.00 to $43.85. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares purchased at each separate price.

Remarks:

	/s/ Donald T. Gardner III, Attorney-in-fact	10/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.